Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
-10.07%
trims when stocks drop
when a holding falls −10%+
Middle response
-6.43%
baseline attrition
Rally response
-13.07%
trims into rallies
when a holding rises +10%+
Top positions · 30
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| ZBHZimmer Biomet Holdings, | $52M | 7.7% | — | 0.3 yr |
| HSICHenry Schein, Inc. | $46M | 6.8% | — | 0.5 yr |
| BDXBecton, Dickinson and Co | $44M | 6.5% | — | 0.5 yr |
| PTCTPTC Therapeutics, Inc. | $41M | 6.0% | — | 0.3 yr |
| DXCMDexCom, Inc. | $34M | 5.0% | — | 0.5 yr |
| ICUIICU Medical, Inc. | $33M | 4.8% | — | 0.5 yr |
| ISRGIntuitive Surgical, Inc. | $31M | 4.6% | — | 0.5 yr |
| RVMDRevolution Medicines, In | $31M | 4.5% | — | 0.5 yr |
| GMEDGlobus Medical, Inc. | $31M | 4.5% | — | 0.5 yr |
| NBIXNeurocrine Biosciences, | $28M | 4.1% | — | 0.3 yr |
| DNLIDenali Therapeutics Inc. | $26M | 3.8% | — | 0.5 yr |
| PACSPACS Group, Inc. | $26M | 3.8% | — | 0.5 yr |
| OLMAOlema Pharmaceuticals, I | $22M | 3.3% | — | 0.5 yr |
| ELANElanco Animal Health Inc | $22M | 3.3% | — | 0.5 yr |
| PFEPfizer Inc. | $19M | 2.9% | — | 0.5 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology33.4%$227M
Medical - Devices28.3%$193M
Medical - Instruments & Supplies11.3%$77M
Drug Manufacturers - General8.2%$56M
Medical - Distribution6.8%$46M
Drug Manufacturers - Specialty & Generic6.1%$41M
Financial - Conglomerates3.8%$26M
Unknown2.1%$15M
Country
US97.5%
Unknown2.1%
GB0.4%
Top 5: 31.9% · Top 10: 54.4% · Top 25: 94.4%
Winners
| Ticker | Prev $ | PnL | YoY % |
|---|
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 15
| ZBH Zimmer Biomet Holdings, Inc.new | +$52M |
| BDX Becton, Dickinson and Company | +$31M |
| NBIX Neurocrine Biosciences, Inc.new | +$28M |
| PTCT PTC Therapeutics, Inc.new | +$26M |
| HSIC Henry Schein, Inc. | +$22M |
| LNTH Lantheus Holdings, Inc.new | +$19M |
| ITGR Integer Holdings Corporationnew | +$19M |
| DXCM DexCom, Inc. | +$18M |
| TNDM Tandem Diabetes Care, Inc.new | +$15M |
| DNLI Denali Therapeutics Inc. | +$14M |
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $680M | 30 | -2.41% | -4.37% | +1.96% | -0.03B |
| 2025-12-31 | $729M | 32 | — | — | — | — |